MVK is a key enzyme of the mevalonate/cholesterol pathway and biallelic hypomorphic mutations in MVK cause mevalonate kinase deficiency (MKD)/hyperimmunoglobulinemia D syndrome (HIDS) (74). This evidence concerns the gene MVK and mevalonic aciduria.